Back to search

Article

Risankizumab and risk of new‑onset depressive episodes and generalized anxiety disorder among adults with psoriasis: a propensity‑matched, real‑world cohort study across 107 health systems

2026-06-02

Abstract excerpt

<title>Abstract</title> <p>Psoriasis is associated with elevated rates of depression and anxiety, yet whether interleukin-23 (IL-23) inhibition relates to incident psychiatric diagnoses in routine care remains unclear. We conducted a retrospective cohort study on the TriNetX Research Network (107 health systems) comparing adults with psoriasis exposed to risankizumab (anti-IL-23 p19) with propensity-matched psori...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3ac513a1-9527-5893-ade5-ab670716a83b
DOI
10.21203/rs.3.rs-9501253/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Risankizumab and risk of new‑onset depressive episodes and generalized anxiety disorder among adults with psoriasis: a propensity‑matched, real‑world cohort study across 107 health systemsDOI 10.21203/rs.3.rs-9501253/v1
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional studySemantic proximity
Psychiatric Disorders and Risk of Psoriasis: Evidence From Cohort Analysis and Mendelian RandomizationSemantic proximity
Understanding the atopic dermatitis-psoriasis phenotypic switch through a mechanistic epidemiology approachSemantic proximity
Association of psoriasis with depression, anxiety, and suicidality: A bidirectional two‐sample Mendelian randomization studySemantic proximity
Exploring comorbidities in Colombian psoriasis patients aged 15+: insights from real-world dataSemantic proximity
Risankizumab: Mechanism of action, clinical and translational scienceSemantic proximity
The impact of biologic treatment in psoriasis patients on COVID-19 infection: A single-center retrospective studySemantic proximity
Increased risk of major depressive disorder among probands with psoriasis and unaffected siblings: a nationwide population‐based studySemantic proximity
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.Semantic proximity
Risk of depression, suicidal ideation, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort studySemantic proximity
Evaluation and management of psoriasis: an internist's guide.Semantic proximity
The Incidence of Immune Mediated Inflammatory Diseases Following COVID-19: a Matched Cohort Study in UK Primary CareSemantic proximity
Select a neighboring publication to make it the new centre.